These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8624431)

  • 1. Effects of a gonadotropin releasing hormone agonist on oocyte maturation, fertilization, and embryonal development of mice.
    Yang BC; Uemura T; Minaguchi H
    J Assist Reprod Genet; 1995 Nov; 12(10):728-32. PubMed ID: 8624431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle.
    Yoshimura Y; Nakamura Y; Ando M; Shiokawa S; Koyama N; Nanno T
    Fertil Steril; 1992 May; 57(5):1091-7. PubMed ID: 1572478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide.
    Kanter M; Sapmaz-Metin M; Serez B
    Arch Gynecol Obstet; 2016 Jan; 293(1):203-209. PubMed ID: 26246413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator in rat oocytes: expression during the periovulatory period, after fertilization, and during follicular atresia.
    Bicsak TA; Cajander SB; Peng XR; Ny T; LaPolt PS; Lu JK; Kristensen P; Tsafriri A; Hsueh AJ
    Endocrinology; 1989 Jan; 124(1):187-94. PubMed ID: 2462486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertilization in vitro of rat oocytes undergoing maturation in response to a GnRH analogue.
    Dekel N; Shalgi R
    J Reprod Fertil; 1987 Jul; 80(2):531-5. PubMed ID: 3309280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
    Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
    Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.
    Gelety TJ; Surrey ES
    J Assist Reprod Genet; 1997 Oct; 14(9):525-30. PubMed ID: 9401871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.
    O'Neill KE; Senapati S; Maina I; Gracia C; Dokras A
    J Assist Reprod Genet; 2016 Sep; 33(9):1175-84. PubMed ID: 27349252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.
    Edelstein MC; Brzyski RG; Jones GS; Oehninger S; Sieg SM; Muasher SJ
    J In Vitro Fert Embryo Transf; 1990 Jun; 7(3):172-6. PubMed ID: 2116488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C mediates gonadotropin-releasing hormone agonist-induced meiotic maturation of follicle-enclosed rabbit oocytes.
    Yoshimura Y; Nakamura Y; Ando M; Jinno M; Nanno T; Oda T; Koyama N; Shiokawa S
    Biol Reprod; 1992 Jul; 47(1):118-25. PubMed ID: 1637939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.
    Serafini P; Stone B; Kerin J; Batzofin J; Quinn P; Marrs RP
    Fertil Steril; 1988 Jan; 49(1):90-5. PubMed ID: 3121401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
    Fauser BC; de Jong D; Olivennes F; Wramsby H; Tay C; Itskovitz-Eldor J; van Hooren HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):709-15. PubMed ID: 11836309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome.
    Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS
    J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.
    Brzyski RG; Muasher SJ; Droesch K; Simonetti S; Jones GS; Rosenwaks Z
    Fertil Steril; 1988 Dec; 50(6):917-21. PubMed ID: 3144467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of homoplastic pituitary pars distalis homogenate (PDH), pregnant mare serum gonadotrophin (PMSG), human chorionic gonadotrophin (HCG), growth hormone (GH), PMSG + GH, and HCG + GH on oocyte recruitment and development in the long-term hypophysectomized frog, Rana cyanophlyctis (Schn).
    Pancharatna M; Saidapur SK
    Gen Comp Endocrinol; 1985 Feb; 57(2):161-71. PubMed ID: 3979800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis.
    Ding N; Liu X; Jian Q; Liang Z; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():92-98. PubMed ID: 28957685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.